Stay updated with breaking news from Nasdaq Blte. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Belite Bio, Inc (NASDAQ:BLTE – Get Free Report) saw strong trading volume on Wednesday . 84,587 shares traded hands during trading, an increase of 45% from the previous session’s volume of 58,272 shares.The stock last traded at $36.91 and had previously closed at $37.88. Wall Street Analysts Forecast Growth A number of analysts […]
Completed enrollment in pivotal Phase 3 “DRAGON” trial for Tinlarebant in adolescent Stargardt disease (“STGD1”) with 104 subjects enrolled across 11...
Belite Bio (NASDAQ:BLTE – Free Report) had its price target boosted by HC Wainwright from $55.00 to $59.00 in a research report report published on Monday, Benzinga reports. They currently have a buy rating on the stock. A number of other analysts have also weighed in on BLTE. SVB Securities started coverage on shares of […]
Belite Bio, Inc (NASDAQ:BLTE – Get Free Report) saw unusually-high trading volume on Tuesday after HC Wainwright raised their price target on the stock from $55.00 to $59.00. HC Wainwright currently has a buy rating on the stock. Approximately 97,119 shares were traded during trading, an increase of 77% from the previous session’s volume of […]
Shares of Belite Bio, Inc (NASDAQ:BLTE – Get Free Report) have earned an average rating of “Buy” from the six brokerages that are covering the stock, Marketbeat.com reports. Six analysts have rated the stock with a buy rating. The average twelve-month price objective among brokerages that have covered the stock in the last year is […]